SocraTec R&D’s Post

Lateral episiotomy or no episiotomy in vacuum assisted delivery in nulliparous women (EVA): multicentre, open label, randomised controlled trial Lateral Episiotomy in Vacuum Assisted Delivery for First-Time Mothers Objective To compare the effect of lateral episiotomy versus no episiotomy on obstetric anal sphincter injury in first-time mothers requiring vacuum extraction. Study Design A multicentre, open label, randomised controlled trial conducted in eight hospitals in Sweden from 2017 to 2023. Participants 717 first-time mothers with a single live fetus of 34 gestational weeks or more, requiring vacuum extraction. Intervention First-time mothers were randomly assigned to receive either a lateral episiotomy or no episiotomy during vacuum extraction. Main Outcome Measures The primary outcome was obstetric anal sphincter injury diagnosed by combined visual inspection and digital examination. Results The study found that lateral episiotomy significantly reduced the risk of obstetric anal sphincter injury compared to no episiotomy in first-time mothers requiring vacuum extraction. Conclusions Lateral episiotomy can be recommended for first-time mothers requiring vacuum extraction to reduce the risk of obstetric anal sphincter injury. Trial Registration ClinicalTrials.gov NCT02643108. https://lnkd.in/g-CNiyrM #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

🔬 Embracing Innovation in Clinical Bioanalysis! 🌐💉 Discover the cutting-edge trends in therapeutic drug monitoring (TDM) with a focus on miniaturization and simplification. 🚀 Currently, dried blood spot (DBS) stands out as a popular microsampling technique—feasible and cost-effective. Yet, challenges like sample homogeneity and volume variability persist. Enter Volumetric Absorptive Microsampling (VAMS), revolutionizing the field by ensuring accurate and precise blood volume collection. 🩸 ✨ VAMS reduces hematocrit effects, enhances volumetric accuracy, and delivers results correlating with dose and drug exposure from wet blood. 📊 💊 This state-of-the-art microsampling technique holds promise, especially in improving adherence to immunosuppressive therapy, particularly in the pediatric population. 🧒🌟 Read more: https://lnkd.in/dQnwgYW8   🩹 Ever had the VAMS experience? Share your thoughts! #ClinicalBioanalysis #TherapeuticDrugMonitoring #InnovationInMedicine #Microsampling #VAMS #HealthcareAdvancements #PediatricCare #ACCORD2024   <a href="https://lnkd.in/dnjawkyG">Obraz autorstwa freepik</a>

Want to dive deeper into IVF automation?   Get access to Dr. Laura Rienzi's full talk from the RM2030 Congress. This compelling presentation explores how automation can revolutionize IVF, leading to improved outcomes and a more personalized experience for patients.   Fill out the form below to receive the full talk straight to your email! https://lnkd.in/dtMgxn3r — Genera, IVI RMA GLOBAL

March is National Endometriosis Month, and it's the perfect time to highlight the ground-breaking strides being made in clinical trials for endometriosis. This spring, Andrew Horne, Professor of Gynaecology and Reproductive Sciences at the University of Edinburgh, is moving a clinical trial of DCA in endometriosis cases into its second phase - with hopes the drug could be prescribed as a treatment on the NHS within the next five years. Clinical research is the driving force behind improved diagnostics, treatments, and, ultimately, enhanced quality of life for those affected by this complex condition. #endometriosisawareness #clinicalresearch

Ophthopedia Update:Five-Year Clinical Trial of Low-concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report: To evaluate (1) the long-term efficacy of low-concentration atropine over 5 years, (2) the proportion of children requiring retreatment and associated factors (3) the efficacy of pro re nata (PRN) retreatment using 0.05% atropine from year 3 to 5. #Ophthalmology #ophthotwitter #eyecare

[🩸Endometriosis - COEMEC accreditation] The Gynecology and Andrology Department at Cliniques universitaires Saint-Luc has been awarded COEMEC accreditation by the Surgical Review Corporation! 🏆👏 They are now the first French-speaking Belgian center recognized as a Center of Excellence in Multidisciplinary Endometriosis Care. This achievement marks more than 40 years of dedicated efforts in the fight against endometriosis. This hormone-dependent disease is characterized by the abnormal presence of endometrial-like tissue outside the uterine cavity, usually associated with an inflammatory process. Endometriosis mainly causes pain during menstruation and intercourse, and is sometimes associated with infertility. Difficult to diagnose, it can significantly alter the quality of life of patients, impacting them sexually, socially, professionally and psychologically. In Belgium, almost 10% of women are thought to be affected. Multidisciplinary teams are working hard to offer cutting-edge care in line with international standards, improving patients' quality of life. #Endometriosis #WomensHealth #COEMEC #Endometriose

LONG month, finally wrapped up PDF build of the Sponsor & Exhibitor Prospectus and registration build for APOPS upcoming #WHEN2024WomensPelvicHealthExpo taking place August 8-9, 2024, here in Milwaukee. Check out APOPS vision, the preliminary program, and view the Atrium booth layout. We anticipate vendor booth spaces and symposium opportunities will fill up fast.   WHEN2024 will be a gathering of female patients’ teens through baby boomers and women’s health diagnostic practitioners, seeking insights about aspects of women’s below-the-waist health from global expert practitioners hailing from multiple countries. Topics covered will include pelvic organ prolapse, urinary incontinence, overactive bladder, fecal incontinence, pain with intimacy, hormones, menopause, fibroids, endometriosis, atrophy, levator avulsion, hysterectomy, mesh, lichen sclerosis, Ehlers Danlos, cosmetic gynecology, and more.   You can snag the Prospectus link and Sponsor/Exhibitor registration info here: https://lnkd.in/ge8kiZTd   Attendee PDF build coming up next! I'll tidy up the pages as soon as I give my eyeballs some shuteye, please excuse any typos!   #APOPS #womenshealthempowerment #EveryVoiceMatters #TheBiggestSecretinWomensHealth

SPECIAL ISSUE ON POST-PARTUM HEMORRHAGE - Heat-stable carbetocin (HSC) and tranexamic acid (TXA) are World Health Organization-recommended medicines that have the potential to address gaps in postpartum hemorrhage (PPH) care in cold chain-challenged settings. Implementation research in varied high-burden settings allows an understanding of the factors that contribute to the successful implementation and integration of recommended interventions into overall PPH care. A Special Collection of articles generate evidence of the benefits and potential challenges related to the introduction of HSC and TXA into postpartum care in public facilities of low-and middle-income countries.

🤔 Was your interest piqued by our infographic on women's health last week? We've got a fantastic article to share with you! 🤝 For our March newsletter, we spoke to Mathieu Horras, CEO and Co-Founder of Aspivix, about how his company is reimagining gynaecology with ‘gentle’ in mind. He told us about his experiences as a man in the world of women’s healthcare and why it's so important to find solutions to the pain so many women experience during routine procedures. 👉 Check out this and many other inspiring #BiopôleStories here: https://lnkd.in/eBdh79Ui

We are deeply convinced that improvement in clinical care of patients depends on the development of much greater interdisciplinary cooperation, standardization of terminology and diagnostic procedures, and systemization of the scattered medical knowledge. Under this light and according to our experience, in obstetrical care, the definition of a new multidisciplinary field of research to be termed “Obstetric Echodynamics” permits to tailor the management strategies of hypertensive disorders and to screen the patient individual risk according to the hemodynamic phenotype. The Obstetric Echodynamist (gynecologist, cardiologist, radiologist…) through the multidisciplinary cardio-obstetric approach, represents the future clinical support in the maternal-fetal wellbeing management. Thanks to all my colleagues for the conceptualization and realization of this new futuristic project!